DelveInsight’s “Parkinson Disease - Market Insights, Epidemiology and Market Forecast – 2023 - 7MM” Reports provides an overview of the disease and global market size of the Parkinson Disease for the 7MM. It also includes global historical and forecasted epidemiological data for the diagnosed prevalent cases of Parkinson Disease from 2010-2023. According to Publisher, the forecasted patient population of Parkinson Disease will increase at a CAGR of XX% from 2010 to 2023 and the worldwide Parkinson Disease market is estimated to be USD XX Million by 2023.
Parkinson's disease (PD) is a disorder caused by the malfunction and death of neurons. It is a chronic and progressive movement disorder which primarily affects neurons in substantia nigra area of the brain. Dopamine is usually responsible for the control and coordination process which is affected when the neuron malfunction and death occurs. As the disease progresses, the amount of dopamine produced in the brain decreases as a result the person is unable to control movement normally. This degenerative disorder affects the central nervous system.
Scope Report covers the disease overview including pathophysiology, symptoms, diagnosis, disease management, and current treatment options. Marketed information including available prescription drugs, its patent and exclusivity details. The Report also covers the detailed global historical and forecasted epidemiological data covering 7MM from 2010-2023. It also provides Market size of Parkinson disease for 7MM from 2010 and forecasted Market size to 2023.